News
MISAM Advocates for Stronger Kratom Regulations and Increased Addiction Medicine Fellowship Funding
On November 19, the Michigan Society of Addiction Medicine (MISAM) sent a letter of support for HB 4969 to members of the House Committee on Regulatory Reform. This bill establishes a regulatory framework for the Department of Licensing and Regulatory Affairs (LARA) to regulate the health and safety of kratom products. Specifically, HB 4969 contains provisions requiring product testing, 2% caps on 7-hydroxymitragynine (7-OH), and protections for individuals under 21 years of age. MISAM praised the legislation as an important step to protect consumers and address the public health risks posed by kratom products.
Additionally, MISAM sent letters to key stakeholders urging them to support allocating a portion of the FY26 opioid settlement funds and FY27 appropriations to support Addiction Medicine Fellowship training in Michigan. Specifically, MISAM requested support from the $5 million year-over-year funding to ensure the sustainability and growth of Michigan’s addiction medicine workforce. In the letter, MISAM touted the benefits of investing in addiction medicine fellowships, including expanding access to high-quality addiction care across Michigan and strengthening a public health-oriented response to the opioid crisis.